The Impact of the Fluid Resuscitation on the Venous Volume and Flow Characteristics in Hypovolemic Shock

the Study Focuses on the Subgoup of Patients With Decreased Effective Blood Volume eg. Trauma Surgical and Non Surgical Patients Clinical Trial

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02474056
• Other study ID #: 0018-09-EMC
• Secondary ID: 0018-09--EMC
• Status: Withdrawn
• Phase: N/A
• First received: June 14, 2015
• Last updated: September 28, 2016
• Start date: January 2010
• Est. completion date: January 2010

Study information

• Verified date: September 2016
• Source: HaEmek Medical Center, Israel
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel:' by ministry of health'
• Study type: Observational

Clinical Trial Summary

We hypothesis that in various situation when the effective blood volume decreased the venous volume flow characteristics change according to the fluid resuscitation

Description:

Patients with clinical signs of loss of the effective blood volume will undergo ultrasound examination of several major veins. The purpose of this examination is to determine vein volume(size) and flow. The ultrasound examination will be done before fluid resuscitation, after fluid administration,and three days after admission

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: January 2010
• Est. primary completion date: January 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age > 18 years old

• decreased effective blood volume

• Systolic blood pressure < 100

• Pulse rate > 110

Exclusion Criteria:

• age <18 years old

• pregnancy

• patient requires urgent surgical intervention

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• the Study Focuses on the Subgoup of Patients With Decreased Effective Blood Volume eg. Trauma Surgical and Non Surgical Patients

Locations

Country	Name	City	State
Israel	Haemek Medical Center	Afula

Sponsors (1)

Lead Sponsor	Collaborator
HaEmek Medical Center, Israel

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	blood volume		1 year	No